欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-JAK/STAT Signaling-STAT-WB436B
WB436B

Chemical Structure : WB436B

CAS No.: 2248552-84-1

WB436B (STAT3 inhibitor WB436B)

货号: PC-49462Not For Human Use, Lab Use Only.

WB436B is a potent and highly selective small molecule inhibitor of STAT3, specifically targets the STAT3-SH2 domain with KD value of 94.3 nM.

规格 价格 库存 数量
5 mg ¥2480 In stock
10 mg ¥3980 In stock
25 mg ¥5980 In stock
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: 99.6% (HPLC) Select Batch:

生物&药学活性

WB436B is a potent and highly selective small molecule inhibitor of STAT3, specifically targets the STAT3-SH2 domain with KD value of 94.3 nM.
WB436B directly binds STAT3 SH2 and STAT3127-722 with KD of 94.3 nM and 129.0 nM, respectively, in Microscale Thermophoresis (MST) assays.
WB436B showed no appreciable binding to other STAT members including STAT1, STAT2, STAT4, STAT5B and STAT6 (KD>10 uM), also exhibits a weak inhibition of a panel of human kinases in vitro.
WB436B shows highly sensitivity to high p-STAT3Tyr705 pancreatic cancer cell lines (IC50<100 nM).
WB436B specifically inhibited IFN-α induced p-STAT3Tyr705, but had no significant inhibition against STAT1 phosphorylation.
WB436B selectively blocked p-STAT3Tyr705 at lower than 100 nM in PANC-1 cells, with minimal impact on JAK1, STAT1, STAT5, AKT and ERK1/2 phosphorylation.
WB436B inhibited STAT3 nuclear translocation, and then deceased the binding between STAT3 with its target genes in pancreatic cancer cells.
WB436B (2.5 and 5 mg/kg/d) inhibited tumor growth and STAT3 activities in the preclinical pancreatic cancer xenografts, suppressed p-STAT3Tyr705 and Ki67 expression, inhibited STAT3 phosphorylation and downstream gene expression in vivo.

物理化学性质&存储条件

分子量 436.490
分子式 C21H20N6O3S
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

3-cyano-N-(2-methoxyphenyl)-2-(1-methyl-1H-pyrazole-4-carboxamido)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-carboxamide

参考文献

1. Huang Chen, et al. Clin Cancer Res. 2022 Nov 14;CCR-22-0997.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: